Infliximab (Remicade(Registered Trademark)) to Treat Dermatomyositis and Polymyositis

This study is ongoing, but not recruiting participants.

Study NCT00033891 Information provided by National Institutes of Health Clinical Center (CC)

First Received: April 11, 2002 Last Updated: October 20, 2009 History of Changes

No Study Results Posted for this Study

Study Status:	This study is ongoing, but not recruiting participants.
Estimated Study Completion Date:	July 2003
Estimated Primary Completion Date:	July 2003 (Final data collection date for primary outcome measure)